Loading clinical trials...
Loading clinical trials...
Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide: A Randomized Clinical Trial
Conditions
Interventions
Calcitonin-gene related peptide (CGRP)
Placebo
Locations
1
Denmark
Rigshospitalet Glostrup
Glostrup Municipality, Denmark
Start Date
June 27, 2025
Primary Completion Date
June 1, 2026
Completion Date
December 30, 2026
Last Updated
August 6, 2025
NCT04715685
NCT06617832
NCT05903040
NCT07342296
NCT05546385
NCT04940390
Lead Sponsor
Danish Headache Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions